Other cytokines produced by NK cells, e.g., TNF-α, GM-CSF, IL-10, and IL-13, may be considered for the evaluation of tumor cell sensitivity to NK cell-mediated killing and could be significant predictive markers for therapy effectiveness (71). The gene discussed is TNF; the disease is neoplasm.